Authors
Latest:
Pointers With Portela: Minimalist Skin Care RoutinesIn this week’s Pointers With Portela, the 208SkinDoc discusses the effectiveness of a minimalist anti-aging skin care routine for patients.
Latest:
Impact of Data on Generalized Pustular PsoriasisAaron S. Farberg, MD, and Jeffrey Crowley, MD, share take-home messages on the impact of the generalized pustular psoriasis study.
Latest:
Addressing the Health Impacts of a Changing ClimateEthan Sims, MD, spoke with Dermatology Times on having positive conversations, cutting down on waste, and how to get involved in change.
Latest:
Unmasking Botulinum Toxin MythsMisleading marketing and incomplete scientific data have led to widespread misinformation about botulinum toxin products.
Latest:
Delving Into NP/PA Perspectives on Emerging Atopic Dermatitis Treatment OptionsExplore how surveyed providers perceive current and emerging therapies in the atopic dermatitis.
Latest:
Jay A. Lieberman, MD, FACAAI: Clinical Pearls and Hands-On Educational Opportunities at ACAAI Annual MeetingProgram Chair Jay A. Lieberman, MD, provides a glimpse into the clinical pearls and dermatological educational opportunities presented at the ACAAI 2023 Annual Scientific Meeting.
Latest:
Key Takeaways on Advanced BCC ManagementPanelists discuss how advanced basal cell carcinoma (BCC) management requires a nuanced approach, emphasizing the importance of early detection, multidisciplinary collaboration, personalized treatment strategies, and ongoing patient monitoring to optimize outcomes and quality of life.
Latest:
QUIZ: Sauna-Related Rash - Test Your Medical Insight“Edward” is a 35-year-old Hispanic male presenting with a new rash on the buttocks which has been present for approximately 1 month.
Latest:
Talking to Patients About the Safety of JAK Inhibitors in Atopic DermatitisPanelists discuss how health care providers can effectively communicate the benefits and risks of JAK inhibitors to patients with atopic dermatitis while addressing safety concerns and establishing realistic treatment expectations.
Latest:
Take-Home Pearls on the Management of Plaque PsoriasisAlexa Hetzel, MS, PA-C; Jennifer Conner, MPAS, PA-C; Terry Faleye, MPAS, PA-C; Laura Bush, DMSc, PA-C; and Lakshi Aldredge, MSN, ANP-BC, share take-home messages regarding the treatment of patients with plaque psoriasis, highlighting listening to and educating patients.
Latest:
The Skin Smart Campus Initiative: Promoting Skin Health and Public Awareness at GWGeorge Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.
Latest:
How Physicians Can Provide Better Care for Patients with Chronic ConditionsTechnology and care navigators are key to managing this growing population
Latest:
Topical Steroid Withdrawal Syndrome Manifesting in Patients Treated for Atopic DermatitisRecent studies show patients are experiencing adverse effects of stopping corticosteroid treatment.
Latest:
Do You Have the Right Financial Adviser?Experts detail 5 tips to ask a financial advisor so they can best serve your interests.
Latest:
Pipeline Updates on the Horizon From Arcutis BiotherapeuticsPatrick Burnett, MD, PhD, shares key updates expected in 2025 for therapeutics treating atopic dermatitis, alopecia areata, and more.
Latest:
Talking to Patients About the Safety of JAK Inhibitors in Atopic DermatitisPanelists discuss how health care providers can effectively communicate the benefits and risks of JAK inhibitors to patients with atopic dermatitis while addressing safety concerns and establishing realistic treatment expectations.
Latest:
Exploring the Diagnostics of Urticaria at ACAAISession at the American College of Allergy, Asthma and Immunology (ACAAI) 2023 Annual Scientific Meeting explored issues in understanding and testing for physical urticaria.
Latest:
Kim Papp, MD, PhD, FRCPC: Exploring the Potential of ESK-001 in Plaque PsoriasisPapp shared insights from the recent STRIDE phase 2 trial, which met all its primary and secondary endpoints. Data was presented at the American Academy of Dermatology Annual Meeting.
Latest:
Talking to Patients About the Safety of JAK Inhibitors in Atopic DermatitisPanelists discuss how health care providers can effectively communicate the benefits and risks of JAK inhibitors to patients with atopic dermatitis while addressing safety concerns and establishing realistic treatment expectations.
Latest:
OX40-Ligand: A Conductor of the Atopic Dermatitis Inflammatory Symphony?Given the complexity of the underlying inflammation in patients with AD, an increased understanding of the OX40L pathway can improve our understanding of AD pathogenesis.
Latest:
Potential Role of AI in HS DiagnosisPanelists discuss how the role of AI in Hidradenitis Suppurativa and the potential for complex multi-input factors.
Latest:
Does diet really play a role in acne?For years, teenagers have been told to avoid certain foods to reduce acne. A review article examines the evidence.
Latest:
An Overview of ArgyriaArgyria is a rare dermatologic condition that presents with blue or grey mucocutaneous discoloration following cutaneous exposure or ingestion of silver.
Latest:
Managing aBCC and aCSCC With Cemiplimab: Tips From Matthew Reynolds, PA-CReynolds discussed what attendees need to know about using cemiplimab to target their difficult skin cancer patients at the Fall Clinical Dermatology Conference for PAs and NPs.
